NAD Press Releases

Health Solutions Commits to Discontinue Claims for ‘PhytoZon’ Supplement Following Challenge by CRN

Healthy Solutions, LLC., has said that it will discontinue challenged advertising claims for the company’s PhytoZon dietary supplement, following an inquiry from the NAD.

Read More

Telebrands Commits to Discontinue Claims for ‘Amish Secret’ Furniture Polish Following Challenge by S.C. Johnson

Telebrands, Inc., has said that it will discontinue product demonstrations and superiority, disparagement and pricing claims for the company’s Amish Secret Furniture Cleaner, following an inquiry from the NAD

Read More

NAD Finds EP Henry Violated NAD Procedures

NAD has determined that EP Henry, a maker of concrete landscaping pavers, violated the procedures that govern the advertising industry’s system of self-regulation. EP Henry promoted the outcome of a case decided by NAD directly to its customers and, in the process, mischaracterized NAD’s findings.

Read More

NAD Recommends Institute for Vibrant Living Discontinue Joint-Pain Claims for ‘Alleviate’ Supplement

NAD has recommended that the Institute for Vibrant Living discontinue a wide range of express claims and testimonials for the company’s Alleviate dietary supplements.

Read More

NAD Recommends TyraTech Discontinue Performance, Efficacy Claims for ‘Vamousse’ Lice Treatments, Finds Company Can Support ‘Pesticide-Free’ Claim

NAD has recommended that TyraTech, Inc. discontinue challenged performance and efficacy claims for the company’s homeopathic Vamousse Lice Treatment and Prevention products, including the claim that its lice treatment product “Kills 100% of lice and eggs in 15 minutes.” NAD determined, however, that advertiser provided a reasonable basis for its “pesticide free” and “No Synthetic Pesticides” claims.

Read More

NAD Recommends Cosmederm Bioscience Discontinue Challenged Claims for TriCalm Anti-Itch Product; Company to Appeal

NAD has recommended that Cosmederm Bioscience, Inc., discontinue advertising claims for the company’s TriCalm over-the-counter (OTC) anti-itch product, following a challenge by Chattem, Inc., the maker of Cortizone-10, an external analgesic formulated with hydrocortisone 1%. Cosmederm has said it will appeal NAD’s decision to the National Advertising Review Board (NARB).

Read More